文献速递糖尿病

十二指肠肌电活动亢进驱动2型糖尿病大鼠模型糖尿病缓解

Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes.
PubMed 文献 · Diabetologia · 2025-12-26

该研究在雄性Sprague Dawley大鼠及高脂饮食/链脲佐菌素(HFD/STZ)诱导的糖尿病大鼠中记录十二指肠肌电活动,并构建胃十二指肠电刺激(ADES)系统以模拟Roux-en-Y胃旁路术(RYGB)相关的肌电亢进。结果显示ADES可复制RYGB的降糖效果并促进胰岛β细胞恢复,且在ZDF大鼠中验证有效,提示靶向十二指肠肌电活动可能成为糖尿病微创治疗替代方案。

要点

  • RYGB在HFD/STZ大鼠中诱导十二指肠肌电亢进,ADES可复制该模式并取得与RYGB相当的降糖效果。
  • ADES降低空腹血糖、使OGTT曲线下面积减少约40%,并使30分钟时间点胰岛素分泌增加71.7%。
  • ADES通过增加β细胞增殖65.3%、减少凋亡39.0%使β细胞质量增加1.5倍,并维持β细胞身份。

核心结论

  • ADES模拟RYGB诱导的十二指肠肌电亢进,可提供与RYGB相当的降糖效果。
  • 靶向十二指肠肌电活动可能为糖尿病治疗提供RYGB的微创替代方案。

研究设计与样本

  • 在雄性Sprague Dawley大鼠及HFD/STZ诱导的糖尿病大鼠中记录十二指肠肌电活动,设或不设RYGB。
  • 构建胃十二指肠电刺激(ADES)系统模拟RYGB相关肌电亢进,并通过降低刺激功率或用苯扎氯铵化学消融肌电活动进行验证。
  • 在雄性ZDF大鼠中进一步验证ADES。

主要发现

  • RYGB在HFD/STZ大鼠中诱导十二指肠肌电亢进,表现为移行性肌电复合波周期缩短、III相持续时间近乎翻倍、进食状态棘波频率增加50.9%。
  • ADES降低空腹血糖、使OGTT曲线下面积减少约40%,并使30分钟时间点胰岛素分泌增加71.7%。
  • 降低刺激功率或苯扎氯铵消融肌电活动可减弱ADES的血糖改善作用。
  • ADES使β细胞质量增加1.5倍,β细胞增殖增加65.3%、凋亡减少39.0%,并上调PDX1和MAFA表达及促进其核定位。
  • 在ZDF大鼠中ADES显著降低120分钟OGTT血糖并使血浆胰岛素水平降低35.1%。

临床怎么用

  • ADES通过复制RYGB相关十二指肠肌电亢进模式实现降糖并促进β细胞恢复,可作为RYGB微创替代策略的探索方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: While Roux-en-Y gastric bypass (RYGB) effectively treats diabetes, its underlying mechanisms remain unclear, highlighting the need to develop less-invasive alternatives. Emerging evidence suggests duodenal involvement in metabolic homeostasis and type 2 diabetes pathophysiology, yet the role of duodenal myoelectrical activity in diabetes and RYGB is poorly understood. This study aims to characterise duodenal myoelectrical changes in diabetes and RYGB, and evaluate their therapeutic potential. METHODS: Duodenal myoelectrical activity was recorded in male Sprague Dawley rats and high-fat diet/streptozocin (HFD/STZ)-induced diabetic rats, with or without RYGB. An antro-duodenum electrical stimulation (ADES) system was developed to mimic RYGB-associated myoelectrical hyperactivity. Its effects were examined by reducing stimulating power or chemically ablating duodenal myoelectrical activity with benzalkonium chloride, alongside pancreatic morphometric analyses. ADES was further validated in male Zucker diabetic fatty (ZDF) rats. RESULTS: RYGB induced duodenal myoelectrical hyperactivity in HFD/STZ rats, characterised by shortened migrating myoelectric complex cycles, a nearly doubled phase III duration, and a 50.9% increase in fed-state spike frequency. By replicating these specific patterns, ADES achieved glucose-lowering effects comparable with those of RYGB, decreasing fasting glucose levels, reducing the OGTT AUC by approximately 40%, and enhancing insulin secretion by 71.7% at the 30 min time point. These glycaemic improvements were attenuated by either reducing the stimulating power or through benzalkonium chloride-mediated ablation of myoelectrical activity. Furthermore, ADES promoted pancreatic beta cell recovery, increasing beta cell mass by 1.5-fold through a 65.3% enhancement in proliferation and a 39.0% reduction in apoptosis. It also preserved beta cell identity, as evidenced by upregulated expression and promoted nuclear localisation of the key transcription factors pancreatic and duodenal homeobox factor-1 (PDX1) and MAF bZIP transcription factor A (MAFA). In ZDF rats, ADES similarly improved glucose homeostasis, significantly lowering 120 min OGTT glucose, and ameliorated hyperinsulinaemia, reducing plasma insulin levels by 35.1%. CONCLUSIONS/INTERPRETATION: ADES mimics RYGB-induced duodenal hyperactivity, offering comparable glucose-lowering effects. Targeting duodenal myoelectrical activity may provide a minimally invasive alternative to RYGB for diabetes treatment.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yun Y, Liu YD, Yang ZM, et al. Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes. Diabetologia. 2025. PMID: 41454013. doi:10.1007/s00125-025-06642-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。